{"name":"Centro de Investigacao em Saude de Manhica","slug":"centro-de-investigacao-em-saude-de-manhica","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"AS-AQ (Carsucam)","genericName":"AS-AQ (Carsucam)","slug":"as-aq-carsucam","indication":"Uncomplicated malaria caused by Plasmodium falciparum","status":"marketed"},{"name":"AL (Coartem)","genericName":"AL (Coartem)","slug":"al-coartem","indication":"Uncomplicated malaria caused by Plasmodium falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"DHP","genericName":"DHP","slug":"dhp","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"AS-AQ (Carsucam)","genericName":"AS-AQ (Carsucam)","slug":"as-aq-carsucam","phase":"marketed","mechanism":"AS-AQ is a fixed-dose artemisinin-based combination antimalarial that kills malaria parasites through multiple mechanisms involving artemisinin and amodiaquine.","indications":["Uncomplicated malaria caused by Plasmodium falciparum","Malaria caused by other Plasmodium species susceptible to artemisinin-based combinations"],"catalyst":""},{"name":"AL (Coartem)","genericName":"AL (Coartem)","slug":"al-coartem","phase":"marketed","mechanism":"Coartem (artemether-lumefantrine) is a fixed-dose combination antimalarial that kills malaria parasites through artemether's rapid parasite clearance and lumefantrine's sustained blood schizonticide activity.","indications":["Uncomplicated malaria caused by Plasmodium falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi"],"catalyst":""},{"name":"DHP","genericName":"DHP","slug":"dhp","phase":"marketed","mechanism":"DHP is a dihydropyridine calcium channel blocker that works by relaxing blood vessels and reducing blood pressure.","indications":["Hypertension","Angina pectoris"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmY3dYMGJtcklOeE0taVdkSXdxS0JQVmdueDB5Z3dCMmgxa25rSnJOeHlpU1g4MGd6SXBUTC1MQloyeVNrMnc3X2tlVGpyZHdGSnkzcHlvcTlQUDJ5ZHJF?oc=5","date":"2025-04-24","type":"trial","source":"Nature","summary":"Knowledge and practices of healthcare professionals regarding antibiotic use in a district hospital, Southern Mozambique: a cross-sectional study | Scientific Reports - Nature","headline":"Knowledge and practices of healthcare professionals regarding antibiotic use in a district hospital, Southern Mozambique","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNNWg3RUFseGQ2OFYzc0xTclkxVk1LOHhoMTNxMkQ3bklmRGtWMWRvbzhrVUQ2OEh1WUhqclFRZWlIZ2FUblZ0ajNJWm0zZFF6VEFPVzFWcks5WFRGSmc0OWkxYkFiMGNldGpzc1N4R2xSbndIVTBZUFhWajdlbk1wV2dGMFV1SW81YjduM3g0d0VxamdsMG1CMw?oc=5","date":"2019-11-01","type":"pipeline","source":"Aidsmap","summary":"Work needed to improve long-term retention in care in Mozambique - Aidsmap","headline":"Work needed to improve long-term retention in care in Mozambique","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":3},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}